Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

REPLIGEN CORP Director's Dealing 2012

Mar 28, 2012

30826_dirs_2012-03-28_945b91df-d9b7-41f3-974e-096da9ee5a61.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2012-03-27

Reporting Person: RUSCHE JAMES R (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-03-27 Common Stock M 25000 $1.83 Acquired 167641 Direct
2012-03-27 Common Stock F 8520 $5.37 Disposed 159121 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-03-27 Stock Option (Right to Buy) $1.83 M 25000 Disposed 2015-05-13 Common Stock (25000) Direct

Footnotes

F1: Payment made via forfeiture of 8,520 shares of Common Stock valued at the Closing Price of $5.37 on March 27, 2012.